AGENUS INC Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
AGENUS INC (AGEN) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $0 for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2014-03-07
- AGENUS INC proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2011-12-31 was $0.00.
- AGENUS INC proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2011-09-30 was $0.00.
- AGENUS INC proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2013 was $0.00.
- AGENUS INC proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- AGENUS INC proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2011 was $5.00M, a 87.50% decline from fiscal 2010.
- AGENUS INC proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2010 was $40.00M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-07 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-07 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-07 | $5.00M 10-K · filed 2014-03-07 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $5.00M 10-Q · filed 2012-11-07 | ||
| 2011-06-30 | $5.00M 10-Q · filed 2012-08-08 | |||
| 2010-12-31 | $40.00M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |